We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+20.94%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$612B
AUM Growth
+$90.2B
Cap. Flow
+$5B
Cap. Flow %
0.82%
Top 10 Hldgs %
32.09%
Holding
12,204
New
1,722
Increased
4,580
Reduced
4,534
Closed
1,264

Top Sells

Rank Stock Value
1
C icon
Citigroup
C
+$703M
2
BAC icon
Bank of America
BAC
+$690M
3
AMZN icon
Amazon
AMZN
+$678M
4
JPM icon
JPMorgan Chase
JPM
+$601M
5
META icon
Meta Platforms (Facebook)
META
+$431M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.11%
2 Technology 2.38%
3 Consumer Discretionary 1.48%
4 Healthcare 0.92%
5 Communication Services 0.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSIAU
10201
DELISTED
TS Innovation Acquisitions Corp. Unit
TSIAU
$146K ﹤0.01%
+13,854
New +$141K
CNSL
10202
CALL
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$145K ﹤0.01%
29,600
-23,400
-44% -$123K
RNET
10203
CALL
DELISTED
RigNet, Inc.
RNET
$145K ﹤0.01%
24,700
+14,100
+133% +$67.8K
TWM icon
10204
CALL
ProShares UltraShort Russell2000
TWM
$44.4M
$144K ﹤0.01%
1,440
-50
-3% -$6.61K
NMTR
10205
CALL
DELISTED
9 Meters Biopharma
NMTR
$144K ﹤0.01%
8,385
+285
+4% +$4.75K
NBRV
10206
PUT
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$144K ﹤0.01%
2,372
+2,231
+1,582% +$242K
BRW
10207
Saba Capital Income & Opportunities Fund
BRW
$331M
$143K ﹤0.01%
15,959
-1,139
-7% -$10K
NGNE icon
10208
Neurogene
NGNE
$736M
$143K ﹤0.01%
506
-140
-22% -$34.2K
CBD
10209
CALL
DELISTED
Companhia Brasileira de Distribuicao
CBD
$143K ﹤0.01%
10,000
-4,900
-33% -$62.6K
ARAV
10210
DELISTED
Aravive, Inc. Common Stock
ARAV
$143K ﹤0.01%
25,364
+14,441
+132% +$79.3K
IRT icon
10211
PUT
Independence Realty Trust
IRT
$3.88B
$142K ﹤0.01%
10,600
-7,100
-40% -$90.8K
MVF
10212
DELISTED
BlackRock MuniVest Fund
MVF
$142K ﹤0.01%
+15,476
New +$138K
TRIB
10213
PUT
Trinity Biotech
TRIB
$7.89M
$142K ﹤0.01%
249
+145
+139% +$72K
FULT icon
10214
CALL
Fulton Financial
FULT
$4.53B
$141K ﹤0.01%
+11,100
New +$132K
MTRX icon
10215
CALL
Matrix Service
MTRX
$310M
$141K ﹤0.01%
12,800
-15,200
-54% -$140K
OESX icon
10216
PUT
Orion Energy Systems
OESX
$109M
$141K ﹤0.01%
+1,430
New +$124K
SD icon
10217
PUT
SandRidge Energy
SD
$518M
$141K ﹤0.01%
45,400
+28,900
+175% +$70.9K
TEN
10218
CALL
Tsakos Energy Navigation Ltd
TEN
$1.27B
$141K ﹤0.01%
17,600
-13,300
-43% -$112K
SRGA
10219
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$141K ﹤0.01%
2,148
+1,634
+318% +$107K
UBA
10220
CALL
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
$141K ﹤0.01%
+10,000
New +$119K
DLNG icon
10221
Dynagas LNG Partners
DLNG
$138M
$140K ﹤0.01%
+56,167
New +$136K
DLNG icon
10222
PUT
Dynagas LNG Partners
DLNG
$138M
$140K ﹤0.01%
55,900
+21,100
+61% +$51K
RC
10223
Ready Capital
RC
$309M
$140K ﹤0.01%
11,219
-6,594
-37% -$81K
CHMA
10224
CALL
DELISTED
Chiasma, Inc. Common Stock
CHMA
$140K ﹤0.01%
32,200
-17,500
-35% -$72.9K
NAVB
10225
CALL
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$140K ﹤0.01%
65,100
-67,200
-51% -$158K

Similar funds

Jeff Yass's Q4 2020 Portfolio in Review

As of Q4 2020, Jeff Yass held 12,204 positions worth $612B, up 17% from $522B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q4 2020 filing shows 1,722 new, 4,580 increased, 4,534 reduced and 1,264 closed positions. Its largest new stake was International Flavors & Fragrances: 726,729 shares worth $79.1M. The largest sale was Citigroup, an estimated $703M.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 93% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q4 2020 buy was International Flavors & Fragrances: 726,729 shares worth $79.1M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $1.46B increase.
  • Jeff Yass's biggest Q4 2020 reduction was Citigroup, cutting an estimated $703M.
  • Jeff Yass fully exited Vanguard Total International Bond ETF in Q4 2020, selling an estimated $146M.
  • Jeff Yass's ten largest holdings make up 32% of its $612B portfolio in Q4 2020.
  • Jeff Yass opened 1,722 new positions and closed 1,264 in Q4 2020.
  • Jeff Yass's portfolio value rose 17% quarter-over-quarter to $612B.

Based on Susquehanna International Group's 13F filing for Q4 2020, filed 16 Feb 2021.